These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2462824)

  • 1. Proliferative responses to acetylcholine receptor peptides in myasthenia gravis.
    Berrih-Aknin S; Cohen-Kaminsky S; Neumann D; Bach JF; Fuchs S
    Ann N Y Acad Sci; 1988; 540():504-5. PubMed ID: 2462824
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood and thymic lymphocyte responses to peptide sequences of the acetylcholine receptor in myasthenia gravis.
    Harcourt G; Sommer N; Rothbard J; Beeson D; Willcox N; Newsom-Davis J
    Ann N Y Acad Sci; 1988; 540():354-6. PubMed ID: 2462811
    [No Abstract]   [Full Text] [Related]  

  • 3. T-cell clones specific to acetylcholine receptor, its subunits, and peptides.
    Fujii Y; Lindstrom J
    Ann N Y Acad Sci; 1988; 540():357-9. PubMed ID: 3264675
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulation of autoimmune helper T lymphocytes from patients with myasthenia gravis with synthetic peptides of the acetylcholine receptor alpha subunit.
    Hohlfeld R; Toyka KV; Miner LL; Conti-Tronconi BM
    Ann N Y Acad Sci; 1988; 540():511-2. PubMed ID: 2462826
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies to synthetic peptide (125-148) of the alpha-subunit of human nicotinic acetylcholine receptor in sera from patients with myasthenia gravis.
    Ohta M; Ohta K; Itoh N; Nishitani H; Hara H; Hayashi K
    Neurology; 1990 Nov; 40(11):1776-8. PubMed ID: 2234435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T-epitope repertoire on the human acetylcholine receptor alpha subunit in severe myasthenia gravis: a study with synthetic peptides.
    Manfredi AA; Protti MP; Wu XD; Howard JF; Conti-Tronconi BM
    Neurology; 1992 May; 42(5):1092-100. PubMed ID: 1374548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis patients, but not healthy subjects, recognize epitopes that are unique to the epsilon-subunit of the acetylcholine receptor.
    Ragheb S; Mohamed M; Lisak RP
    J Neuroimmunol; 2005 Feb; 159(1-2):137-45. PubMed ID: 15652413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic peptide of human acetylcholine receptor alpha-subunit sequence 125-147 (methionine 144), a more potent autoantigen than its norleucine 144 analog.
    Lennon VA; Huang ZX; McCormick DJ; Griesmann GE; Fujii N; Lambert EH
    Ann N Y Acad Sci; 1988; 540():516-9. PubMed ID: 2462827
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-nicotinic receptor autoimmunity in myasthenia gravis. Establishment of specific T-helper cell lines and identification of sensitizing epitopes on the alpha-subunit.
    Hohlfeld R; Toyka K; Heininger K; Tzartos SJ; Walgrave SL; Protti P; Conti-Tronconi BM
    Monogr Allergy; 1988; 25():50-67. PubMed ID: 2459613
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs.
    Katz-Levy Y; Kirshner SL; Sela M; Mozes E
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7000-4. PubMed ID: 7688469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor.
    Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM
    J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of CD4+ T cells from myasthenic patients and healthy subjects of biosynthetic and synthetic sequences of the nicotinic acetylcholine receptor.
    Diethelm-Okita B; Wells GB; Kuryatov A; Okita D; Howard J; Lindstrom JM; Conti-Fine BM
    J Autoimmun; 1998 Apr; 11(2):191-203. PubMed ID: 9650099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between the epsilon and gamma subunits of the acetylcholine receptor (AChR) may be significant in autoimmune myasthenia gravis.
    Ragheb S; Lisak RP
    Ann N Y Acad Sci; 2003 Sep; 998():336-8. PubMed ID: 14592892
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the alpha subunit.
    Oshima M; Ashizawa T; Pollack MS; Atassi MZ
    Eur J Immunol; 1990 Dec; 20(12):2563-9. PubMed ID: 2269324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.
    Im SH; Barchan D; Souroujon MC; Fuchs S
    J Immunol; 2000 Oct; 165(7):3599-605. PubMed ID: 11034361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis.
    Manfredi AA; Protti MP; Bellone M; Moiola L; Conti-Tronconi BM
    J Lab Clin Med; 1992 Jul; 120(1):13-21. PubMed ID: 1377215
    [No Abstract]   [Full Text] [Related]  

  • 18. Acetylcholine receptor-specific human T-lymphocyte lines.
    Hohlfeld R; Toyka KV; Michels M; Heininger K; Conti-Tronconi B; Tzartos SJ
    Ann N Y Acad Sci; 1987; 505():27-38. PubMed ID: 2446551
    [No Abstract]   [Full Text] [Related]  

  • 19. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
    Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
    Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies as probes for acetylcholine receptor epitopes in thymuses and thymic epithelial tumors of patients with myasthenia gravis and nonmyasthenic controls.
    Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
    Ann N Y Acad Sci; 1988; 540():508-10. PubMed ID: 2462825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.